Dana Investment Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Dana Investment Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-37,622	Closed	-$592K	–	541
2024 Q1	$592K	Buy	37,622 +5,109	+16%	+$78.6K	0.02%	421
2023 Q4	$524K	Sell	32,513 -2,661	-8%	-$33.9K	0.03%	321
2023 Q3	$447K	Sell	35,174 -142	-0.4%	-$1.96K	0.02%	323
2023 Q2	$497K	Buy	35,316 +870	+3%	+$12.4K	0.02%	317
2023 Q1	$532K	Sell	34,446 -993	-3%	-$16.6K	0.03%	304
2022 Q4	$581K	Buy	+35,439	New	+$576K	0.03%	292

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Dana Investment Advisors's DCPH Position: Q2 2024 in Review

Dana Investment Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 37,622 shares — an estimated $592K sold.

Dana Investment Advisors first reported a position in DCPH in Q4 2022 and held it in 6 quarters. The position peaked at $592K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Dana Investment Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Dana Investment Advisors sold 37,622 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $592K.
Dana Investment Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
Dana Investment Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $592K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Dana Investment Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.